Grantham, Mayo, Van Otterloo & Co (GMO)
GOCO

Grantham, Mayo, Van Otterloo & Co (GMO)’s GoHealth GOCO Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio GOCO Stock Details GOCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-14,106
Closed -$278K – 619
2023
Q2 		$278K Hold
14,106
– – ﹤0.01% 612
2023
Q1 		$230K Sell
14,106
-2,300
-14% -$35.5K ﹤0.01% 639
2022
Q4 		$171K Sell
16,406
-9,787
-37% -$86.9K ﹤0.01% 687
2022
Q3 		$139K Sell
26,193
-23,007
-47% -$173K ﹤0.01% 691
2022
Q2 		$441K Buy
49,200
+6,967
+16% +$81K ﹤0.01% 626
2022
Q1 		$748K Buy
+42,233
New +$1.31M ﹤0.01% 558

Other funds holding GOCO

CP
Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
GCM
Glendon Capital Management Santa Monica, California $805M AUM 17.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s GOCO Position: Q3 2023 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of GoHealth (GOCO) in Q3 2023, closing a stake of 14,106 shares — an estimated $278K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in GOCO in Q1 2022 and held it in 6 quarters. The position peaked at $748K in Q1 2022. 44 funds tracked by Wall St. Rank hold GOCO as of Q3 2023.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining GoHealth position as of Q3 2023 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 14,106 GoHealth shares in Q3 2023, an estimated $278K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in GoHealth in Q1 2022 and held it in 6 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s GoHealth position peaked at $748K in Q1 2022.
  • 44 funds tracked by Wall St. Rank held GoHealth as of Q3 2023.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2023, filed 13 Nov 2023.